Franklyn G. Prendergast, M.D., Ph.D. (2014)
Franklyn G. Prendergast is an independent director at Eli Lilly and Company, where he also serves as a member of the Public Policy & Compliance Committee and a member of the Science & Technology Committee.
Prendergast also is a member of the Life Sciences Advisory Board of Safeguard Scientifics, Inc., and a member of several prominent national and academic boards. He serves as the director of the Mayo Clinic Center for Individualized Medicine, LifeSync Holdings, Inc., St. Mary’s and Methodist Hospitals in Rochester, the Translational Genomics Research Institute, GMP Companies Inc., Cellumen, Inc., the Hamm Clinic, the Infectious Diseases Research Institute and the Board on Radiation Effects Research of the National Academy of Sciences. He is also a former director of the Mayo Clinic Cancer Center and a current trustee of the Mayo Foundation.
Prendergast has been a member of Scientific Advisory Board of Cepheid since 2007 and also serves on the Board of Scientific Advisors for the National Cancer Institute. He is a member of the American Chemical Society Committee on Chemistry and Public Affairs, American Society for Photobiology, American Association for the Advancement of Science, Biophysical Society, Sigma Xi and American Society for Biochemistry and Molecular Biology. Prendergast has served NIH extensively over the past 20 years, with roles on numerous advisory groups and boards.
Prendergast completed his doctorate in biochemistry from the University of Minnesota in 1977 and a master’s degree in physiology from Oxford University in 1979.
Social Media Links